Key result
Specific leukocyte microRNA expression levels are altered in carotid atherosclerosis.
Why the study?
MicroRNAs have emerged as important factors in the pathogenesis of atherosclerosis, but their expression in leukocytes of patients with carotid atherosclerosis requires evaluation.
Population
Patients with carotid atherosclerosis
Comparison
Leukocyte expression levels of specific microRNAs
Design
Observational study
Authors
Loading...
Should not yet alter clinical management of carotid atherosclerosis; supports further research into these miRNAs as potential biomarkers.
Observational
Leukocyte expression of specific microRNAs shows significant differences in patients with carotid atherosclerosis, suggesting their potential utility as biomarkers or therapeutic targets.
Раскуражев et al. (2020) conducted an observational in Carotid atherosclerosis. MicroRNA leukocyte expression (miR-126, miR-29a, miR-33a, miR-21) was evaluated on Molecular levels of microRNAs and their correlations. Leukocyte expression of specific microRNAs (miR-126, miR-29a, miR-33a, miR-21) showed statistically significant differences between patient groups with carotid atherosclerosis.
Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context: